TCF7L2-related neurodevelopmental disorder
MONDO:0100525
A neurodevelopmental disorder caused by a variation in the TCF7L2 gene. This disorder is characterised by speech delay, craniofacial dysmorphism, ophthalmologic conditions including myopia, autism, intellectual disability, attention deficit hyperactivity disorder, and orthopaedic abnormalities. Phenotypic severity is variable and does not cluster by variant type or genomic locus.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.